The efficacy of amrubicin third‐line chemotherapy in patients with relapsed extensive‐disease small‐cell lung cancer: A retrospective and historical study in a single institute

Amrubicin monotherapy for elderly patients with relapsed extensive-disease small-cell lung cancer: A retrospective study

(2018) Hideyuki Sone et al.   Thoracic Cancer

Real-world treatment patterns and outcomes of patients with small cell lung cancer progressing after 2 lines of therapy

(2018) Anna D. Coutinho et al.   LUNG CANCER

Comparison of irinotecan/platinum versus etoposide/platinum chemotherapy for extensive-stage small cell lung cancer: A meta-analysis

(2017) D. Han et al.   EUROPEAN JOURNAL OF CANCER CARE

Phase II study of Amrubicin monotherapy in elderly or poor-risk patients with extensive disease of small cell lung cancer

(2017) Satoshi Igawa et al.   INVESTIGATIONAL NEW DRUGS

Amrubicin for relapsed small-cell lung cancer: a systematic review and meta-analysis of 803 patients

(2016) Nobuyuki Horita et al.   Scientific Reports

Recommendations for the Use of WBC Growth Factors: American Society of Clinical Oncology Clinical Practice Guideline Update

(2015) Thomas J. Smith et al.   JOURNAL OF CLINICAL ONCOLOGY

Randomized phase II trial comparing amrubicin with re-challenge of platinum doublet in patients with sensitive-relapsed small-cell lung cancer: North Japan Lung Cancer Study Group trial 0702

(2015) Akira Inoue et al.   LUNG CANCER

Randomized Phase III Trial of Amrubicin Versus Topotecan As Second-Line Treatment for Patients With Small-Cell Lung Cancer

(2014) Joachim von Pawel et al.   JOURNAL OF CLINICAL ONCOLOGY

A single-arm confirmatory study of amrubicin therapy in patients with refractory small-cell lung cancer: Japan Clinical Oncology Group Study (JCOG0901)

(2014) Haruyasu Murakami et al.   LUNG CANCER

Evaluation of Amrubicin as a Third or Later Line of Chemotherapy for Advanced Non-Small Cell Lung Cancer

(2013) Satoshi Igawa et al.   CHEMOTHERAPY

Third-Line Chemotherapy in Small-Cell Lung Cancer: An International Analysis

(2013) Demetrios Simos et al.   Clinical Lung Cancer

Efficacy and safety of amurubicin for the elderly patients with refractory relapsed small cell lung cancer as third-line chemotherapy

(2012) Nobuhiro Asai et al.   Journal of Cancer Research and Therapeutics

A Meta-Analysis of Randomized Controlled Trials Comparing Irinotecan/Platinum with Etoposide/Platinum in Patients with Previously Untreated Extensive-Stage Small Cell Lung Cancer

(2010) Jingwei Jiang et al.   Journal of Thoracic Oncology

Camptothecins Compared with Etoposide in Combination with Platinum Analog in Extensive Stage Small Cell Lung Cancer: Systematic Review with Meta-Analysis

(2010) João Paulo S.N. Lima et al.   Journal of Thoracic Oncology

Amrubicin at a lower-dose with routine prophylactic use of granulocyte-colony stimulating factor for relapsed small-cell lung cancer

(2010) Akito Hata et al.   LUNG CANCER

Small Cell Lung Cancer

(2009) Taimur Sher et al.   MAYO CLINIC PROCEEDINGS